Avadel Pharmaceuticals (AVDL) Preferred Stock Liabilities: 2012-2014
Historic Preferred Stock Liabilities for Avadel Pharmaceuticals (AVDL) over the last 3 years, with Dec 2014 value amounting to -$104.7 million.
- Avadel Pharmaceuticals' Preferred Stock Liabilities fell 77.70% to -$104.7 million in Q4 2014 from the same period last year, while for Dec 2014 it was -$104.7 million, marking a year-over-year decrease of 77.70%. This contributed to the annual value of -$104.7 million for FY2014, which is 77.70% down from last year.
- According to the latest figures from FY2014, Avadel Pharmaceuticals' Preferred Stock Liabilities is -$104.7 million, which was down 77.70% from -$58.9 million recorded in FY2013.
- In the past 5 years, Avadel Pharmaceuticals' Preferred Stock Liabilities ranged from a high of -$2.6 million in FY2012 and a low of -$104.7 million during FY2014.
- Over the past 3 years, Avadel Pharmaceuticals' median Preferred Stock Liabilities value was -$58.9 million (recorded in 2013), while the average stood at -$55.4 million.
- Data for Avadel Pharmaceuticals' Preferred Stock Liabilities shows a maximum YoY slumped of 2,165.12% (in 2013) over the last 5 years.
- Avadel Pharmaceuticals' Preferred Stock Liabilities (Yearly) stood at -$2.6 million in 2012, then plummeted by 2,165.12% to -$58.9 million in 2013, then crashed by 77.70% to -$104.7 million in 2014.